Valproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?
about
Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medicationsMetabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.Influence of maternal obesity, diet and exercise on epigenetic regulation of adipocytes.Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study
P2860
Valproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Valproic Acid as a potentiator ...... : fat chance, or slim to none?
@en
type
label
Valproic Acid as a potentiator ...... : fat chance, or slim to none?
@en
prefLabel
Valproic Acid as a potentiator ...... : fat chance, or slim to none?
@en
P2093
P2860
P1476
Valproic Acid as a potentiator ...... : fat chance, or slim to none?
@en
P2093
Brant E Fries
Kristina Szafara
Randolph Regal
P2860
P304
P577
2015-02-01T00:00:00Z